Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001021408-03-005105
Filing Date
2003-03-27
Accepted
2003-03-26 21:30:26
Documents
5
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1061004
3 AGREEMENT DATED DECEMBER 31, 2002 BETWEEN PANGENE CORPORATION AND THE COMPANY dex1030.htm EX-10.30 279356
4 FOURTH AMENDMENT TO LEASE BETWEEN THE COMPANY AND GUNBARREL FACILITY L.L.C. dex1031.htm EX-10.31 23993
5 CONSENT OF ERNST AND YOUNG LLP dex231.htm EX-23.1 5122
6 CERTIFICATION dex99.htm EX-99 4291
  Complete submission text file 0001021408-03-005105.txt   1375855
Mailing Address 6304 SPINE RD UNIT A BOULDER CO 80301
Business Address 6304 SPINE RD UNIT A BOULDER CO 80301 3035303891
NAPRO BIOTHERAPEUTICS INC (Filer) CIK: 0000891504 (see all company filings)

EIN.: 841187753 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-24320 | Film No.: 03619309
SIC: 2833 Medicinal Chemicals & Botanical Products